W. L. Gore & Associates Inc – Product Pipeline Analysis, 2016 Update

GlobalDataが発行した調査報告書(GDME2057PD)
◆英語タイトル:W. L. Gore & Associates Inc - Product Pipeline Analysis, 2016 Update
◆商品コード:GDME2057PD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年12月28日
◆ページ数:44
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
W. L. Gore & Associates Inc (Gore) carries out manufacturing and marketing of fluoro-polymer products for the medical, electronics, nuclear, fabrics and industrial markets. The company’s medical division provides surgeons and patients a variety of surgical products and medical OEM products. Its implants portfolio includes materials and components that solve complex medical problems in vascular, endovascular, interventional, general surgery and cardiothoracic, oral and orthopedic procedures. Gore caters to aerospace, automotive, chemical processing, computer, telecommunications, electronics, energy, environmental, industrial, manufacturing, military, pharmaceutical, biotechnology, and textile markets. The company has manufacturing facilities in the US, Scotland, Germany, China and Japan. Gore is headquartered in Delaware, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company W. L. Gore & Associates Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
W. L. Gore & Associates Inc Company Overview 6
W. L. Gore & Associates Inc Company Snapshot 6
W. L. Gore & Associates Inc Pipeline Products and Clinical Trials Overview 7
W. L. Gore & Associates Inc – Pipeline Analysis Overview 9
Business Description 9
Key Facts 9
W. L. Gore & Associates Inc – Major Products and Services 11
W. L. Gore & Associates Inc Pipeline Products by Development Stage 14
W. L. Gore & Associates Inc Clinical Trials by Trial Status 16
W. L. Gore & Associates Inc Pipeline Products Overview 18
BioTREK 18
BioTREK Product Overview 18
GORE Carotid Stent 19
GORE Carotid Stent Product Overview 19
GORE EXCLUDER Conformable AAA Endoprosthesis 20
GORE EXCLUDER Conformable AAA Endoprosthesis Product Overview 20
GORE EXCLUDER Conformable AAA Endoprosthesis Clinical Trial 21
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis 22
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Product Overview 22
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Clinical Trial 23
GORE HELEX Septal Occluder – PFO 24
GORE HELEX Septal Occluder – PFO Product Overview 24
GORE HELEX Septal Occluder – PFO Clinical Trial 25
GORE TAG Thoracic Branch Endoprosthesis 26
GORE TAG Thoracic Branch Endoprosthesis Product Overview 26
GORE TAG Thoracic Branch Endoprosthesis Clinical Trial 27
W. L. Gore & Associates Inc – Key Competitors 30
W. L. Gore & Associates Inc – Key Employees 31
W. L. Gore & Associates Inc – Key Employee Biographies 32
W. L. Gore & Associates Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
W. L. Gore & Associates Inc, Recent Developments 35
Dec 15, 2016: W. L. Gore & Associates Receives Innovative Technology Designation from Vizient for GORE SYNECOR Biomaterial 35
Nov 15, 2016: Gore Global Registry for Endovascular Aortic Treatment Completes Enrollment 35
Sep 27, 2016: New Technology Add-On Payment Awarded for GORE EXCLUDER Iliac Branch Endoprosthesis 36
Sep 20, 2016: One-Year Results in Japanese Clinical Study Affirms the GORE VIABAHN Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease 37
Sep 19, 2016: First Implant Completed in Pivotal Study of GORE TAG Thoracic Branch Endoprosthesis 37
Sep 07, 2016: GORE VIABAHN Endoprosthesis Marks 20 Years of Proven Performance 38
Aug 30, 2016: GORE DrySeal Flex Introducer Sheath Advances Care through Access 39
Aug 02, 2016: GORE TIGRIS Vascular Stent Gains FDA Approval for Treatment of Peripheral Artery Disease 39
Jun 28, 2016: GORE VIABAHN Endoprosthesis Found to Provide Superior Patency and Reduced Interventions Versus Balloon Angioplasty Alone for Challenging AV Access Cases 40
Jun 08, 2016: Market-leading TEVAR Device is First to Surpass 100,000 Devices Distributed Worldwide 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
W. L. Gore & Associates Inc Pipeline Products and Clinical Trials Overview 7
W. L. Gore & Associates Inc Pipeline Products by Equipment Type 7
W. L. Gore & Associates Inc Pipeline Products by Indication 8
W. L. Gore & Associates Inc Clinical Trials by Trial Status 8
W. L. Gore & Associates Inc, Key Facts 10
W. L. Gore & Associates Inc, Major Products and Services 11
W. L. Gore & Associates Inc Number of Pipeline Products by Development Stage 14
W. L. Gore & Associates Inc Pipeline Products Summary by Development Stage 15
W. L. Gore & Associates Inc Clinical Trials by Trial Status 16
W. L. Gore & Associates Inc Clinical Trials Summary 17
BioTREK - Product Status 18
BioTREK - Product Description 18
GORE Carotid Stent - Product Status 19
GORE Carotid Stent - Product Description 19
GORE EXCLUDER Conformable AAA Endoprosthesis - Product Status 20
GORE EXCLUDER Conformable AAA Endoprosthesis - Product Description 20
GORE EXCLUDER Conformable AAA Endoprosthesis - Assessment of the GORE EXCLUDER Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms 21
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis - Product Status 22
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis - Product Description 22
GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis - Early Feasibility Assessment of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Type IV Thoracoabdominal Aortic Aneurysms Involving the Visceral Branch Vessels 23
GORE HELEX Septal Occluder - PFO - Product Status 24
GORE HELEX Septal Occluder - PFO - Product Description 24
GORE HELEX Septal Occluder - PFO - Gore Helex Septal Occluder / Gore Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-confirmed Tia in Patients with Patent Foramen Ovale (PFO) 25
GORE TAG Thoracic Branch Endoprosthesis - Product Status 26
GORE TAG Thoracic Branch Endoprosthesis - Product Description 26
GORE TAG Thoracic Branch Endoprosthesis - Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (Branched TAG Device) in the Treatment of Aortic Arch Aneurysms 27
GORE TAG Thoracic Branch Endoprosthesis - Evaluation of the GORE TAG Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta 27
GORE TAG Thoracic Branch Endoprosthesis - Evaluation of the Gore Tag Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta 28
GORE TAG Thoracic Branch Endoprosthesis - Evaluation of the GORE TAG Thoracic Branch Endoprosthesis in the Treatment of Proximal Descending Thoracic Aortic Aneurysms 28
GORE TAG Thoracic Branch Endoprosthesis - GORE TAG Thoracic Branch Endoprosthesis Early Feasibility Study 29
GORE TAG Thoracic Branch Endoprosthesis - Pivotal Study of GORE TAG Thoracic Branch Endoprosthesis 29
W. L. Gore & Associates Inc, Key Employees 31
W. L. Gore & Associates Inc, Key Employee Biographies 32
Table 1: W. L. Gore & Associates Inc, Other Locations 33
W. L. Gore & Associates Inc, Subsidiaries 33

List of Figures
W. L. Gore & Associates Inc Pipeline Products by Equipment Type 8
W. L. Gore & Associates Inc Pipeline Products by Development Stage 14
W. L. Gore & Associates Inc Clinical Trials by Trial Status 16

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ W. L. Gore & Associates Inc – Product Pipeline Analysis, 2016 Update(W. L. Gore & Associates Inc - Product Pipeline Analysis, 2016 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆